# EDGAR Filing Document

**Accession Number:** 0001021412
**File Stem:** 0001493152-25-014310
**Filing Date:** 2025-9
**Character Count:** 10371
**Document Hash:** 68c2c40ca78656cf610edf79ceb0c7d5
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001493152-25-014310.hdr.sgml**: 20250919

**ACCESSION NUMBER**: 0001493152-25-014310

**CONFORMED SUBMISSION TYPE**: SCHEDULE 13D/A

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20250919

**DATE AS OF CHANGE**: 20250919

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Aspira Women's Health Inc.
- **CENTRAL INDEX KEY:** 0000926617
- **STANDARD INDUSTRIAL CLASSIFICATION:** IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 330595156
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D/A
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 005-60711
- **FILM NUMBER:** 251327640

**BUSINESS ADDRESS:**
- **STREET 1:** 12117 BEE CAVES ROAD BUILDING THREE
- **STREET 2:** SUITE 100
- **CITY:** AUSTIN
- **STATE:** TX
- **ZIP:** 78738
- **BUSINESS PHONE:** 512-519-0400

**MAIL ADDRESS:**
- **STREET 1:** 12117 BEE CAVES ROAD BUILDING THREE
- **STREET 2:** SUITE 100
- **CITY:** AUSTIN
- **STATE:** TX
- **ZIP:** 78738

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** VERMILLION, INC.
- **DATE OF NAME CHANGE:** 20070824

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** CIPHERGEN BIOSYSTEMS INC
- **DATE OF NAME CHANGE:** 20000316

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** ABIOTIC SYSTEMS
- **DATE OF NAME CHANGE:** 19950407
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** SCHULER JACK W
- **CENTRAL INDEX KEY:** 0001021412

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D/A

**MAIL ADDRESS:**
- **STREET 1:** PO BOX 531
- **CITY:** LAKE BLUFF
- **STATE:** IL
- **ZIP:** 60044

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## SCHEDULE 13D

### Under the Securities Exchange Act of 1934

**(Amendment No. 18)**

**Aspira Women's Health Inc.**

*(Name of Issuer)*

**Common Stock, $0.001 par value**

*(Title of Class of Securities)*

**04537Y208**

*(CUSIP Number)*

**Jack W. Schuler**<br>PO Box 531<br>Lake Bluff IL 60044<br>(520) 906-2991

*(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)*

**09/17/2025**

*(Date of Event Which Requires Filing of this Statement)*

| **CUSIP No.** | **04537Y208** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**SCHULER JACK W** | Name of reporting person<br>**SCHULER JACK W** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[ ] (a)<br>[x] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[ ] (a)<br>[x] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**PF** | Source of funds (See Instructions)<br>**PF** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**X1** | Citizenship or place of organization<br>**X1** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**6536.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**3823829.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**6536.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**3823829.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**3830365.00** | Aggregate amount beneficially owned by each reporting person<br>**3830365.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**9.1%** | Percent of class represented by amount in Row (11)<br>**9.1%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**IN** | Type of Reporting Person (See Instructions)<br>**IN** | |

---

| **CUSIP No.** | **04537Y208** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Jack W. Schuler Living Trust** | Name of reporting person<br>**Jack W. Schuler Living Trust** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[ ] (a)<br>[x] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[ ] (a)<br>[x] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**WC** | Source of funds (See Instructions)<br>**WC** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**ILLINOIS** | Citizenship or place of organization<br>**ILLINOIS** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**3823829.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**3823829.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**3823829.00** | Aggregate amount beneficially owned by each reporting person<br>**3823829.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**9.1%** | Percent of class represented by amount in Row (11)<br>**9.1%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**IN** | Type of Reporting Person (See Instructions)<br>**IN** | |

---

**Item 1. Security and Issuer**

**(a) Title of Class of Securities:**
Common Stock, $0.001 par value

**(b) Name of Issuer:**
Aspira Women's Health Inc.

**(c) Address of Issuer's Principal Executive Offices:**
12117 BEE CAVES ROAD BUILDING THREE, Suite 100, Austin, TX, 78738

**Item 4. Purpose of Transaction**

This Amendment No. 18 to Schedule 13D (this "Amendment") hereby amends and supplements Item 4 by adding the following thereto: "The disclosure set forth in Items 5 and 6 below is hereby incorporated by reference in this Item 4. On September 17, 2025, the Trust purchased from the Issuer the Common Stock and September 2025 Warrants pursuant to the September 2025 Purchase Agreement (in each case as defined and further described in Item 6 below)."

**Item 5. Interest in Securities of the Issuer**

**(a)**
This Amendment hereby amends and restates Item 5(a) in its entirety as follows: "The information set forth in Rows 7 through 13 of the cover page hereto for each of Mr. Schuler and the Trust is incorporated herein by reference. The percentage amount set forth in Row 13 for all cover pages filed herewith is calculated based upon the 35,655,918 Shares outstanding as of August 8, 2025, as reported by the Issuer in its Form 10-Q filed with the Securities and Exchange Commission (the "SEC") on August 13, 2025 plus the 6,550,000 shares of Common Stock sold pursuant to the September 2025 Purchase Agreement for a total of 42,205,918 Shares outstanding."

**(b)**
This Amendment hereby amends and restates Item 5(b) in its entirety as follows: "The information set forth in Rows 7 through 13 of the cover page hereto for each of Mr. Schuler and the Trust is incorporated herein by reference."

**(c)**
This Amendment hereby amends and restates Item 5(c) in its entirety as follows: "Neither Mr. Schuler nor the Trust has effected any transactions in the Shares during the 60 days prior to the date hereof."

**Item 6. Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer.**

This Amendment hereby amends and supplements Item 6 by adding the following thereto:

"The disclosure set forth in Items 4 and 5 above is hereby incorporated by reference in this Item 6.

September 2025 Purchase Agreement and Common Stock and September 2025 Warrant

On September 16, 2025, the Trust entered into a Securities Purchase Agreement, dated as of such date, among the Issuer, the Trust, and the other purchasers party thereto (the "September 2025 Purchase Agreement"), pursuant to which the Trust purchased from the Issuer the Common Stock and September 2025 Warrant (as defined below). The September 2025 Purchase Agreement contained customary terms and conditions.

The foregoing description of the September 2025 Purchase Agreement does not purport to be complete and is qualified in its entirety by reference to the form thereof attached hereto as Exhibit 16, which exhibit is hereby incorporated herein by reference.

On September 16, 2025, pursuant to the September 2025 Purchase Agreement, the Trust purchased from the Issuer 1,111,111 shares of Common Stock (the "Common Stock") and a warrant to purchase 833,333 shares of Common Stock (the "September 2025 Warrant").  The September 2025 Warrant is exercisable at $0.75 per share for five (5) years from the date of issuance.

The foregoing description of the September 2025 Warrant does not purport to be complete and is qualified in its entirety by reference to the form thereof attached hereto as Exhibit 17, which exhibit is hereby incorporated herein by reference."

### SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** SCHULER JACK W

**Signature:** /s/ Jack W Schuler

**Name/Title:** Jack W. Schuler

**Date:** 09/18/2025

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Jack W. Schuler Living Trust

**Signature:** /s/ Jack W Schuler

**Name/Title:** Jack W Schuler, Sole Trustee

**Date:** 09/18/2025